| Total n = 344 | TTR ≤ 70% n = 283 | TTR > 70% n = 61 | OR | 95%CI | p |
Age < 60 years | 183 (53.2) | 140 (49.5) | 43 (70.5) | 2.44 | 1.34 - 4.43 | 0.003 |
Male | 151 (43.9) | 117 (41.34) | 34 (55.74) | 1.78 | 1.02 - 3.12 | 0.04 |
Urban residence | 326 (94.8) | 268 (94.7) | 58 (95.1) | 1.08 | 0.30 - 3.84 | 0.90 |
University level | 84 (24.4) | 68 (24.3) | 16 (26.2) | 1.12 | 0.59 - 2.11 | 0.71 |
Total autonomy | 309 (89.8) | 251 (88.7) | 58 (95.1) | 2.46 | 0.72 - 8.32 | 0.14 |
INR monitoring by the patient himself | 240 (69.8) | 188 (66.4) | 52 (85.3) | 2.91 | 1.37 - 6.17 | 0.005 |
High blood pressure | 92 (26.7) | 80 (28.3) | 12 (19.7) | 0.62 | 0.31 - 1.23 | 0.17 |
Diabetes | 18 (5.2) | 15 (5.3) | 3 (4.9) | 0.92 | 0.25 - 3.29 | 0.90 |
Obesity | 9 (2.6) | 6 (2.1) | 3 (4.2) | 2.38 | 0.58 - 9.82 | 0.22 |
Heart failure | 115 (33.4) | 97 (34.3) | 18 (29.5) | 0.80 | 0.43 - 1.46 | 0.47 |
Fluindione | 246 (71.5) | 189 (66.8) | 57 (93.4) | 7.08 | 2.49 - 20.1 | 0.0002 |
≥3 medications | 202 (58.7) | 175 (61.8) | 27 (4.3) | 175 | 0.28 - 0.85 | 0.01 |
Loop diuretics | 173 (50.3) | 146 (51.6) | 27 (44.3) | 0.74 | 0.42 - 1.29 | 0.30 |
Spironolactone | 151 (43.9) | 130 (45.9) | 21 (34.4) | 0.61 | 0.34 - 10 | 0.10 |
Beta blockers | 159 (46.2) | 138 (48.8) | 21 (34.4) | 0.55 | 0.30 - 0.98 | 0.04 |
ACE inhibitors | 158 (45.9) | 137 (48.4) | 21 (34.4) | 0.55 | 0.31 - 0.99 | 0.04 |
Digoxin | 18 (5.2) | 12 (4.2) | 6 (9.8) | 2.46 | 0.88 - 6.84 | 0.08 |
Proton pump inhibitors | 68 (19.8) | 50 (17.7) | 18 (29.5) | 1.95 | 1.03 - 3.66 | 0.03 |
Low-dose aspirin | 30 (8.7) | 18 (6.4) | 12 (19.7) | 3.60 | 1.63 - 7.95 | 0.001 |
≥365 days of anticoagulation | 271 (78.8) | 223 (78.8) | 48 (78.7) | 1.00 | 0.51 - 1.97 | 0.98 |